Similar to CTLA-4, binding of programmed death-1 (PD-1) by its ligand (PD-L1), which is overexpressed on the surface of some cancer cells, releases signals that inhibit T cell activation and promote tumor-cell evasion (14, 15). The gene discussed is PDCD1; the disease is neoplasm.